Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Finding Rac1 Activators in Human Podocytes

FY 2015-16

Summary
Chronic kidney disease affects over 3 million Canadians and leads to end stage renal disease and loss of kidney function, making it a serious health problem. However, treatment of chronic kidney disease remains non-specific. Understanding the mechanisms by which chronic kidney disease progresses to end stage renal disease is vital for finding novel therapeutic targets. A hallmark of chronic kidney disease is proteinuria, protein leakage from the blood into the urine. Heavy proteinuria is known to accelerate the progression of chronic kidney disease. Proteinuria is caused by morphological changes in podocytes, specialized epithelial cells in the kidney's basic filtration unit. Rho-family small GTPases (Rho-GTPases), such as Rac1, play a role in determining podocyte morphology. Mutations resulting in increased Rac1 activation have been found in proteinuric patients. Rac1 hyperactivation causes podocyte damage and proteinuria in animal models. Guanine nucleotide exchange factors (GEFs) are known to activate Rho-GTPases; however, there are many members of GEFs and it is unknown which GEFs play a role in activating Rac1 in podocytes during proteinuria. The current proposal aims to elucidate which GEFs activate Rac1 in human podocytes when they are injured. Finding GEFs responsible for Rac1 hyperactivation will provide novel targets for therapies aimed at alleviating proteinuria and stopping the progression of chronic kidney disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
350175
Name
Maier Mirela
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Finding Rac1 Activators in Human Podocytes
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Kidney Disease; Guanine Nucleotide Exchange Factors; Podocytes; Proteinuria; Rac1 Hyperactivity; Trio
Abstract
Chronic kidney disease affects over 3 million Canadians and leads to end stage renal disease and loss of kidney function, making it a serious health problem. However, treatment of chronic kidney disease remains non-specific. Understanding the mechanisms by which chronic kidney disease progresses to end stage renal disease is vital for finding novel therapeutic targets. A hallmark of chronic kidney disease is proteinuria, protein leakage from the blood into the urine. Heavy proteinuria is known to accelerate the progression of chronic kidney disease. Proteinuria is caused by morphological changes in podocytes, specialized epithelial cells in the kidney's basic filtration unit. Rho-family small GTPases (Rho-GTPases), such as Rac1, play a role in determining podocyte morphology. Mutations resulting in increased Rac1 activation have been found in proteinuric patients. Rac1 hyperactivation causes podocyte damage and proteinuria in animal models. Guanine nucleotide exchange factors (GEFs) are known to activate Rho-GTPases; however, there are many members of GEFs and it is unknown which GEFs play a role in activating Rac1 in podocytes during proteinuria. The current proposal aims to elucidate which GEFs activate Rac1 in human podocytes when they are injured. Finding GEFs responsible for Rac1 hyperactivation will provide novel targets for therapies aimed at alleviating proteinuria and stopping the progression of chronic kidney disease.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Maier, Mirela
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~